AG-120 (Ivosidenib): Mechanism of Action

AG-120 (Ivosidenib) MOA:Targeting IDH1/D-2-HG Metabolic Pathway for Acute Myeloid Leukemia

🎯 check AG-120 (Ivosidenib) product page

AG-120 (Ivosidenib) is a potent, selective IDH1 inhibitor. It affects metabolic, epigenetic, and HR repair signaling pathways, by binding to IDH1 to reduce 2-HG levels and targeting YTHDC2, effectively inhibiting cancer cell survival and promoting cellular differentiation and apoptosis.

Primary Applications and Mechanism of Action